Instituto Oncológico de Andalucía,
http://www.nejm.org/doi/full/10.1056/NEJMoa1714448?query=TOC.Wo315tTc1QU.linkedin
http://www.nejm.org/doi/full/10.1056/NEJMoa1714448?query=TOC.Wo315tTc1QU.linkedin
This paper evaluates the efficacy and safety of larotrectinib, a highly-selective TRK inhibitor used to treat adults and…
Efficacy of #Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. @weldiery @FoxChaseCancer https://t.co/EULtMWXN…
N Engl J Med. 2018 Feb 22;378(8):731-739. doi: 10.1056/NEJMoa1714448. Research Support, Non-U.S. Gov't; Research Support, N.I.H.…
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children